Initially studied in cystic fibrosis patients because of the positive effect of P2Y2R agonists on mucociliary clearance mediated by the inhibition of the epithelial sodium channel ENaC (162), new studies reported the involvement of P2Y2R signaling in wound healing. The gene discussed is P2RY2; the disease is cystic fibrosis.